Search Results - "Haydock, Mark"
-
1
720 CUE-102 selectively activates and expands WT1-specific T cells for the treatment of patients with WT1+ malignancies
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundWilms' Tumor 1 (WT1) was ranked as the highest priority antigen for therapeutic targeting in an effort by the National Cancer Institute. Development…”
Get full text
Journal Article -
2
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies
Published in Clinical cancer research (15-04-2020)“…To assess the potential for CUE-101, a novel therapeutic fusion protein, to selectively activate and expand HPV16 E7 -specific CD8 T cells as an off-the shelf…”
Get full text
Journal Article -
3
354 A phase 1 trial of CUE-101 a novel HPV16 E7-pHLA-IL2-Fc fusion protein in patients with recurrent/metastatic HPV16+ head and neck cancer
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundImmuno-STATsTM are novel, modular fusion proteins designed to selectively activate tumor-antigen-specific CD8+ T cells. Human papillomavirus (HPV)…”
Get full text
Journal Article -
4
The influence of railways on the development of accrington and district, 1848-1914
Published 01-01-2009“…The project explores the complex and counter-intuitive historical relationships between railways and development through a local study of Accrington and the…”
Get full text
Dissertation